PMID: 42460021

Cardiovascular toxicity of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in HR+/HER2- breast cancer: a real-world study based on the FAERS database.

Ma Shuai, Li Lu, Chen Yanwei, Zhao Yongshun

Frontiers in pharmacology · 2026

Vol. 17, pp. 1831639

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.